Use of Alcohol and Tobacco in medicine is
undermining efforts to fight cancer in LMICs
The use of known carcinogens, such as alcohol and tobacco, in medical treatments and products can indeed pose significant challenges to cancer prevention, management, and control,
Alcohol as a Carcinogen:
Alcohol is classified as a known
human carcinogen1.
The National Cancer Institute states
that the risk of developing alcohol-associated cancers increases with the
amount of alcohol consumed over time1.
The International Agency for Research
on Cancer (IARC) has found that even moderate alcohol consumption can increase
the risk of several types of cancer2.
The Centers for Disease Control and
Prevention (CDC) also acknowledges that reducing alcohol use may reduce the
risk of cancer3.
The utilization of alcohol in traditional medicine within low- and middle-income countries (LMICs) indeed exacerbates the challenges associated with cancer prevention. This is largely due to prevailing attitudes and misconceptions about cancer and its relationship with alcohol use.
Alcohol Use in
Traditional Medicine:
In LMICs, alcohol is often used in
traditional medicine practices for its supposed therapeutic properties1.
These practices can include the use
of alcohol as a solvent for herbal concoctions or as a standalone remedy
believed to have health benefits1.
Impact on Cancer Prevention Efforts:
The World Health Organization (WHO)
has identified alcohol consumption as a risk factor for several types of
cancer, including breast, liver, and colorectal cancers2.
Despite this, the use of alcohol in
traditional medicine can perpetuate the belief that alcohol has
health-promoting qualities, which contradicts scientific evidence2.
Attitudes and Misconceptions:
Attitudes towards alcohol use in
traditional medicine can influence public perceptions and behaviors related to
cancer prevention3.
Misconceptions about the medicinal
value of alcohol can lead to its increased consumption, thereby elevating the
risk of developing alcohol-related cancers3.
Challenges in Changing Perceptions:
Addressing
the deeply ingrained beliefs and practices related to the use of alcohol in
traditional medicine requires a nuanced approach that respects cultural
identities while promoting evidence-based health practices.
Understanding Cultural Context:
Traditional medicine is not merely a set of
practices; it’s often a part of the cultural heritage and identity of a
community.
Any attempt to change these practices must start
with a deep understanding of their cultural significance and the reasons behind
their persistence.
Culturally Sensitive Health Education:
Health education campaigns need to be designed with
cultural sensitivity to ensure they are effective and respectful.
These campaigns should engage with community
leaders and healers who hold influence and can act as bridges between modern
medicine and traditional practices.
Collaborative Approach:
Collaboration between healthcare professionals and
traditional medicine practitioners can create a platform for dialogue and
knowledge exchange.
This collaborative approach can help integrate
beneficial traditional practices with modern medical knowledge, leading to more
holistic healthcare solutions.
Empowering Communities:
Empowerment involves providing communities with the
information they need to make informed decisions about their health.
Educational initiatives should aim to empower
rather than dictate, allowing individuals to choose healthier practices without
feeling that their cultural practices are being undermined.
Tailored Messaging:
Messages should be tailored to address specific
misconceptions and provide clear, evidence-based information about the risks
associated with alcohol use in medicine.
The messaging should also highlight alternative
practices that align with cultural values but do not pose health risks.
Policy Support:
Supportive policies that regulate the use of
alcohol in traditional medicines can reinforce educational efforts.
These policies should be developed in consultation
with the communities they affect to ensure they are culturally appropriate and
effective.
Overall,
changing deep-rooted beliefs and practices related to alcohol use in
traditional medicine is a complex challenge that requires a respectful,
informed, and community-centric approach. Culturally sensitive health education
campaigns, collaborative efforts, and supportive policies are key to addressing
misconceptions without dismissing the value of traditional medicine. This
multifaceted strategy can contribute to more effective cancer prevention and
control in low- and middle-income countries.
Educational Interventions:
Educational interventions that
provide accurate information about the risks associated with alcohol use,
including its carcinogenic potential, are essential1.
These interventions should aim to empower
individuals with knowledge, enabling them to make informed decisions about
their health.
Policy Implications:
Policymakers in LMICs face the task
of integrating evidence-based cancer prevention strategies with respect for
traditional practices1.
Regulations may be needed to control the use of
alcohol in medicinal products, ensuring that public health is not compromised.
Generally,
while traditional medicine is an integral part of healthcare in many LMICs, the
inclusion of alcohol as a medicinal component poses significant challenges for
cancer prevention. Addressing the attitudes and misconceptions about alcohol’s
role in medicine requires a multifaceted approach that includes education,
policy change, and cultural sensitivity.
Tobacco and Cancer in Low- and Middle-Income
Countries:
Tobacco smoking is a well-recognized
risk factor for the initiation and spread of several cancers4.
The burden of cancers attributable to
tobacco smoking is found to be higher in males and is positively associated
with the socio-economic development of countries4.
Patterns of tobacco use in low and
middle-income countries vary by product and socio-demographic characteristics,
with the highest prevalence often reported in men, those with lower education,
less household wealth, living in rural areas, and higher age5.
The use
of tobacco in traditional medicines, particularly in the form of snuff, is a
practice that persists in various low- and middle-income countries (LMICs).
This practice has significant implications for public health, especially
concerning cancer morbidity and mortality.
Tobacco Use in Traditional Medicines:
In many LMICs, tobacco is not only
consumed for pleasure but also used in traditional medicines, often in the form
of snuff1.
Snuff can be either inhaled through
the nose (nasal snuff) or placed in the mouth (oral snuff), where the nicotine
is absorbed through the mucous membranes1.
Health Implications:
The World Health Organization (WHO)
recognizes that smokeless tobacco products, including snuff, are associated
with several health risks, including cancer2.
The Global Burden of Disease study
estimates that smokeless tobacco use, such as chewing tobacco and snuff, caused
approximately 349,000 deaths in 20191.
Cultural and Socioeconomic Factors:
The prevalence and patterns of
tobacco use, including snuff, vary widely across countries, regions, and
socioeconomic groups within LMICs1.
Men, individuals with lower
education, less household wealth, those living in rural areas, and older age
groups are often found to have higher prevalence rates of tobacco use1.
Challenges in Cancer Control:
The incorporation of tobacco in traditional
medicines complicates efforts to reduce the cancer burden in LMICs.
Cultural acceptance and the perceived medicinal
value of tobacco in these contexts can lead to normalization of its use, making
public health interventions more challenging.
Policy and Education:
Effective tobacco control policies and educational
campaigns are needed to address the use of tobacco in traditional medicines.
Policies should be culturally sensitive and
consider the traditional uses of tobacco while educating about its risks.
Public health strategies must also focus on
debunking myths about the medicinal benefits of tobacco and promoting healthier
alternatives.
In
general, the use of tobacco in traditional medicines, such as snuff, in LMICs
contributes to the high burden of cancer morbidity and mortality. Efforts to
combat cancer must address these cultural practices by implementing targeted
policies and educational initiatives that consider the socioeconomic and
cultural contexts of these communities.
Attitudes Towards Carcinogens in Medicine:
Attitudes towards addressing alcohol
consumption in healthcare settings can influence individuals’ behaviors related
to alcohol use and abuse6.
Awareness of the link between alcohol
and different types of cancer is generally low, which may contribute to the
continued use and abuse of alcohol7.
Implications for Cancer Control Efforts:
Efforts to combat cancer must consider the complex
interplay between socio-economic factors, cultural attitudes, and the
availability of carcinogenic substances in medical products.
Public health strategies should include education
on the risks associated with alcohol and tobacco use, as well as policies to
limit their inclusion in medicinal products.
Addressing these underpinnings is crucial for
reducing the burden of cancer morbidity and mortality, particularly in low- and
middle-income countries where the impact is amplified.
Therefore,
the presence of carcinogens like alcohol and tobacco in medicines, especially
in low- and middle-income countries, significantly contributes to the global
cancer burden. Changing attitudes towards these substances and implementing
robust prevention strategies are imperative for effective cancer control.
The
combined impact of alcohol and tobacco use indeed has a multiplicative
synergistic effect on carcinogenesis, making the battle against cancer even
more complex. When these substances are used
together, they significantly increase the risk of developing cancers,
particularly those of the oral cavity, oropharynx, larynx, and esophagus1. For instance, individuals who consume
both alcohol and tobacco are at a 5-fold increased risk of
developing these cancers compared to those who use either substance alone2. For heavy users, this risk can be up
to 30 times higher2.
This
synergistic effect is due to several factors:
- Alcohol may enhance the
carcinogenic effects of tobacco by increasing the production of enzymes
that convert tobacco tar into carcinogens3.
- Combined use may also compound
the inflammation caused by each habit, further increasing the risk3.
Given
this synergy, efforts to combat just one carcinogen may indeed be less
effective if used in isolation. A comprehensive approach that addresses both
alcohol and tobacco use is necessary for effective cancer prevention.
Moreover,
the cultural milieu and social drivers of tobacco and alcohol use demand
focused attention. These include:
- Societal Influences: Advertising, marketing, and
social media play significant roles in shaping behaviors and norms around
alcohol and tobacco use4.
- Cultural Norms: Cultural acceptance and
traditional practices can normalize the use of these substances, making it
challenging to change behaviors4.
- Socio-Economic Factors: Economic development, poverty,
and education levels influence patterns of substance use and can
exacerbate health disparities5.
- Policy and Regulation: The implementation and
enforcement of alcohol and tobacco policies vary widely, impacting
consumption patterns6.
To
address these challenges, a multi-faceted strategy is required:
- Public
Health Campaigns: These should aim to educate about the
risks of combined alcohol and tobacco use and promote healthy behaviors.
- Policy
Interventions: Regulations that control advertising,
pricing, and availability of alcohol and tobacco can help reduce
consumption.
- Community
Engagement: Working with community leaders and
members to understand cultural contexts and develop tailored
interventions.
- Healthcare
Integration: Incorporating substance use screening
and counseling into routine healthcare can help identify and address risky
behaviors early.
Overall,
the twin impact of alcohol and tobacco use on carcinogenesis is a public health
concern that requires a concerted effort that spans education, policy, and
community engagement to effectively mitigate the heightened risk of cancer
associated with these substances.
Recommended Reading
1. Global
Burden of Disease [database] Washington, DC Institute of Health Metrics 2019.
IHME, accessed 17 July 2021.
2. WHO
International, Health topics, Tobacco, Fact sheet Last updated on 26th July
2021.
3. Tata
Institute of Social Sciences (TISS), Mumbai and Ministry of Health and Family
Welfare, GoI. GATS. GATS 2 India 2016-17.
4. Tata
Institute of Social Sciences (TISS), Mumbai and Ministry of Health and Family
Welfare, GoI. GATS. GATS 2 Delhi. 2016-17.
5. International
Institute for Population Sciences (IIPS) and ICF. 2021. National Family Health
Survey (NFHS-5), 2019-21: India: Volume I Mumbai IIPS.
6. Balan B,
Elazan S, Morillas M, Sandberg A Disease load in Aliganj, an urban village in
New Delhi, India: a search for directions in risk reduction through urban
planning. Project of knowledge community on children in India in collaboration
with Department of Community Medicine, VMMC, New Delhi.
7. World
Health Organization. Noncommunicable disease surveillance, monitoring and
reporting. Global Adult Tobacco Survey. Available from: https://www.who.int/teams/noncommunicable-diseases/surveillance/systems-tools/global-adult-tobacco-survey.
8. Heatherton
TF, Kozlowski LT, Frecker RC, Fagerström KO The Fagerström test for nicotine
dependence: A revision of the Fagerström tolerance questionnaire. Br J Addict
1991;86:1119–27. doi: 10.1111/j. 1360-0443.1991.tb01879.x.
9. Kumar R,
Kant S, Chandra A, Krishnan A Tobacco use and nicotine dependence among newly
diagnosed pulmonary tuberculosis patients in Ballabgarh tuberculosis unit,
Haryana. J Family Med Prim Care 2020;9:2860–5.
10. Mattingly
DT, Hirschtick JL, Fleischer NL Unpacking the non-hispanic other category:
Differences in patterns of tobacco product use among youth and adults in the
United States, 2009-2018. J Immigr Minor Health 2020;22:1368–72.
11. Kypriotakis
G, Robinson JD, Green CE, Cinciripini PM Patterns of tobacco product use and
correlates among adults in the population assessment of tobacco and health
(PATH) study: A latent class analysis. Nicotine Tob Res 2018;20 suppl_1 S81–7.
12. Johnson
AL, Collins LK, Villanti AC, Pearson JL, Niaura RS Patterns of nicotine and
tobacco product use in youth and young adults in the United States, 2011-2015.
Nicotine Tob Res 2018;20 suppl_1 S48–54.
13. Rath JM,
Villanti AC, Abrams DB, Vallone DM Patterns of tobacco use and dual use in US
young adults: The missing link between youth prevention and adult cessation. J
Environ Public Health 2012 2012. 679134.
14. Villanti
AC, Pearson JL, Cantrell J, Vallone DM, Rath JM Patterns of combustible tobacco
use in U. S. young adults and potential response to graphic cigarette health
warning labels. Addict Behav 2015;42:119–25.
15. Tan C,
Lin L, Lim M, Ong SK, Wong ML, Lee JK Tobacco use patterns and attitudes in
Singapore young male adults serving military national service: A qualitative
study. BMJ Open 2020;10:e039367.
16. Blazer
DG, Wu LT Patterns of tobacco use and tobacco-related psychiatric morbidity and
substance use among middle-aged and older adults in the United States. Aging
Ment Health 2012;16:296–304.
17. Kumar R,
Kant S, Chandra A, Krishnan A Tobacco use and nicotine dependence among
patients with diabetes and hypertension in Ballabgarh, India. Monaldi Arch
Chest Dis 2021.
18. Divinakumar
KJ, Patra P, Prakash J, Daniel A Prevalence and patterns of tobacco use and
nicotine dependence among males industrial workers. Ind Psychiatry J
2017;26:19–23.
Comments
Post a Comment